Week in Review: China Resources Pharma to Raise $2 Billion in Hong Kong IPO
September 10, 2016 at 14:42 PM EDT
China Resources Pharma, China's second largest drugmaker, has been approved to stage its IPO on the Hong Kong Exchange, and will raise as much as $2 billion.
